SOPHiA GENETICS Stock (NASDAQ:SOPH)


ForecastOwnershipChartTranscripts

Previous Close

$8.36

52W Range

$3.10 - $8.98

50D Avg

$6.89

200D Avg

$5.41

Market Cap

$644.32M

Avg Vol (3M)

$445.41K

Beta

0.98

Div Yield

-

SOPH Company Profile


SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CH

Employees

415

IPO Date

Jul 23, 2021

Website

SOPH Performance


Latest Earnings Call Transcripts


Q2 26Aug 04, 26 | 8:00 AM
Q1 26May 05, 26 | 8:00 AM
Q4 25Mar 03, 26 | 8:00 AM

Peer Comparison


TickerCompany
SLPSimulations Plus, Inc.
NRCNRC Health
NAKANakamoto Inc.
ACIUAC Immune S.A.
OPRXOptimizeRx Corp.
DHDefinitive Healthcare Corp.
CLLSCellectis S.A.
AGLAgilon Health, Inc.
LRMRLarimar Therapeutics, Inc.
ANROAlto Neuroscience, Inc.